Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (42)
Lawrence S. Engel, Emily C. Zabor, Jaya Satagopan, Anders Widell, Nathaniel Rothman, Thomas R. O'Brien, Mingdong Zhang, Stephen K. Van Den Eeden & Tom K. Grimsrud. (2019) Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case–control study nested within two prospective cohorts. International Journal of Cancer 145:9, pages 2360-2371.
Crossref
Crossref
Serkan YALAKİ & Mehmet Suat YALÇIN. (2019) Prevalence of occult hepatitis B infection in patients with cryptogenic cirrhosisKriptojenik sirozlu hastalarda okült hepatit B sıklığı. Cukurova Medical Journal 44:3, pages 753-757.
Crossref
Crossref
Qixia Wang, Paul Klenerman & Nasser Semmo. (2017) Significance of anti-HBc alone serological status in clinical practice. The Lancet Gastroenterology & Hepatology 2:2, pages 123-134.
Crossref
Crossref
Eva Mortensen, Amanda Kamali, Patricia L. Schirmer, Cynthia Lucero-Obusan, Carla A. Winston, Gina Oda, Mark A. Winters, Janet Durfee, Richard A. Martinello, Victoria J. Davey & Mark Holodniy. (2016) Are current screening protocols for chronic hepatitis B virus infection adequate?. Diagnostic Microbiology and Infectious Disease 85:2, pages 159-167.
Crossref
Crossref
J.L. Horan, J.E. Stout & B.D. Alexander. (2014) Hepatitis B core antibody‐positive donors in cardiac transplantation: a single‐center experience. Transplant Infectious Disease 16:5, pages 859-863.
Crossref
Crossref
Jae Young JangEui Ju Park. (2013) Occult Hepatitis B Virus Infection in Chronic Hepatitis C. The Korean Journal of Gastroenterology 62:3, pages 154.
Crossref
Crossref
M. Yuefeng, F. Weili, T. Wenxiang, X. Ligang, L. Guiling, G. Hongwei, L. Wencai, W. Xiaoguang, M. Wei & F. Zhongyi. (2011) Long‐term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation. Clinical Transplantation 25:4, pages 517-522.
Crossref
Crossref
Jae Young JangSoung Won JeongSung Ran CheonSae Hwan LeeSang Gyune KimYoung Koog CheonYoung Seok KimYoung Deok ChoHong Soo KimSo Young JinYun Soo KimBoo Sung Kim. (2011) Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients. The Korean Journal of Hepatology 17:3, pages 206.
Crossref
Crossref
R. A. A. Pondé, D. D. P. Cardoso & M. O. Ferro. (2009) The underlying mechanisms for the ‘anti-HBc alone’ serological profile. Archives of Virology 155:2, pages 149-158.
Crossref
Crossref
Nimer Assy, Zaza Beniashvili, Agness Djibre, Gattas Nasser, Maria Grosovski & William Nseir. (2009) Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg(-) chronic hepatitis B patients from inactive chronic carriers. World Journal of Gastroenterology 15:24, pages 3025.
Crossref
Crossref
A. R. C. Motta-Castro, R. M. B. Martins, N. M. Araujo, C. Niel, G. B. Facholi, B. V. Lago, F. C. A. Mello & S. A. Gomes. (2008) Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Archives of Virology 153:12, pages 2197-2205.
Crossref
Crossref
SABAHATTIN OCAK & ALI FUAT ESKIOCAK. (2008) The evaluation of immune responses to hepatitis B vaccination in diabetic and non‐diabetic haemodialysis patients and the use of tetanus toxoid. Nephrology 13:6, pages 487-491.
Crossref
Crossref
A.‐R. El‐Zayadi, E. H. Ibrahim, H. M. Badran, A. Saeid, N. A. Moneib, M. A. Shemis, R. M. Abdel‐Sattar, A. M. Ahmady & A. El‐Nakeeb. (2008) Anti‐HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfusion Medicine 18:1, pages 55-61.
Crossref
Crossref
Alexandra Valsamakis. (2007) Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B. Clinical Microbiology Reviews 20:3, pages 426-439.
Crossref
Crossref
MK Osborn, JL Guest & D Rimland. (2007) Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. HIV Medicine 8:5, pages 271-279.
Crossref
Crossref
Stephen N. Wong, Chi-Jen Chu, Chun-Tao Wai, Terese Howell, Charles Moore, Robert J. Fontana & Anna S.F. Lok. (2007) Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy. Liver Transplantation 13:3, pages 374-381.
Crossref
Crossref
Jeong Heo, Won Ook Go, Gwang Ha Kim, Dae Hwan Kang, Geun Am Song, Mong Cho, Hyung Hoi Kim & Eeu Yup Lee. (2006) HBV DNA Quantitation Using Real-time PCR. Annals of Laboratory Medicine 26:6, pages 424-430.
Crossref
Crossref
Voranush ChongsrisawatNutchanart ThawornsukApiradee TheamboonlersSuda LouisirirotchanakulYong Poovorawan. (2006) Hepatitis B Virus DNA in Unusual Serological Profiles of Hepatitis B Surface Antigen-Positive Sera. Viral Immunology 19:4, pages 623-629.
Crossref
Crossref
Steven D. Mawhorter & Robin K. Avery. (2006) Can Donors With Prior Hepatitis Be Safely Used for Heart Transplantation?. The Journal of Heart and Lung Transplantation 25:7, pages 805-813.
Crossref
Crossref
Chun-Jen Liu, Ding-Shinn Chen & Pei-Jer Chen. (2006) Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 36, pages S33-S44.
Crossref
Crossref
Chun-Jen Liu, Shyh-Chyi Lo, Jia-Horng Kao, Ping-Tsung Tseng, Ming-Yang Lai, Yen-Hsuan Ni, Shiou-Hwei Yeh, Pei-Jer Chen & Ding-Shinn Chen. (2006) Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. Journal of Hepatology 44:1, pages 39-46.
Crossref
Crossref
K. PogányH.L. ZaaijerJ.M. PrinsF.W. Wit, J.M.A. LangeM.G.H.M. Beld. (2005) Occult Hepatitis B Virus Infection before and 1 Year after Start of HAART in HIV Type 1-Positive Patients. AIDS Research and Human Retroviruses 21:11, pages 922-926.
Crossref
Crossref
C.M.D. Silva, C. Costi, C. Costa, C. Michelon, R. Oravec, A.B. Ramos, C. Niel & M.L. Rossetti. (2005) Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. Journal of Infection 51:1, pages 24-29.
Crossref
Crossref
F. Fabrizi, P. G. Messa, G. Lunghi, F. Aucella, S. Bisegna, S. Mangano, M. Villa, F. Barbisoni, E. Rusconi & P. Martin. (2005) Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Alimentary Pharmacology & Therapeutics 21:11, pages 1341-1347.
Crossref
Crossref
Eric Q. Konnick, Maria Erali, Edward R. Ashwood & David R. Hillyard. (2005) Evaluation of the COBAS Amplicor HBV Monitor Assay and Comparison with the Ultrasensitive HBV Hybrid Capture 2 Assay for Quantification of Hepatitis B Virus DNA. Journal of Clinical Microbiology 43:2, pages 596-603.
Crossref
Crossref
Bernard Weber & Annemarie Berger. (2005) Molecular detection of hepatitis B virus: recent developments. Molekularer Nachweis des Hepatitis B-Virus: Aktueller Entwicklungsstand. LaboratoriumsMedizin 29:1, pages 33-43.
Crossref
Crossref
G. Gessoni, P. Barin, S. Valverde, A. Giacomini, C. Di Natale, E. Orlandini, N. Arreghini, G. De Fusco, A. Frigato, M. Fezzi, F. Antico & G. Marchiori. (2004) Biological qualification of blood units. Transfusion and Apheresis Science 30:3, pages 197-203.
Crossref
Crossref
Shahika Aytay, Asa Ohagen, Michael P. Busch, Bernadette Alford, John R. Chapman & Aris Lazo. (2004) Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivation. Transfusion 44:4, pages 476-484.
Crossref
Crossref
J.‐P. Allain. (2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis 86:2, pages 83-91.
Crossref
Crossref
Jean-Pierre Allain. (2004) Occult hepatitis B virus infection. Transfusion Clinique et Biologique 11:1, pages 18-25.
Crossref
Crossref
Christian Drosten, Thomas Nippraschk, Christoph Manegold, Helga Meisel, Veronika Brixner, W.Kurt Roth, Anani Apedjinou & Stephan Günther. (2004) Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. Journal of Clinical Virology 29:1, pages 59-68.
Crossref
Crossref
Andre F Charest, Anne Grand'Maison, James McDougall & Marc B Goldstein. (2003) Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. American Journal of Kidney Diseases 42:6, pages 1193-1199.
Crossref
Crossref
F. Fabrizi, S. Bunnapradist, G. Lunghi, M. Villa & P. Martin. (2018) Transplanting Solid Organs from HBsAg Negative Donors Positive for Antibody to Hepatitis B Core Antigen: The Implications. The International Journal of Artificial Organs 26:11, pages 972-983.
Crossref
Crossref
Emanuel K Manesis, George V Papatheodoridis, Vasilios Sevastianos, Evangelos Cholongitas, Christos Papaioannou & Stephanos J Hadziyannis. (2003) Significance of Hepatitis B Viremia Levels Determined by A Quantitative Polymerase Chain Reaction Assay in Patients With Hepatitis B E Antigen–Negative Chronic Hepatitis B Virus Infection. American Journal of Gastroenterology 98:10, pages 2261-2267.
Crossref
Crossref
Marı́a Buti, Antoni Mas, Martı́n Prieto, Fernando Casafont, Antonio González, Manuel Miras, Jose-Ignacio Herrero, Rossendo Jardı́, Eva Cruz de Castro & César Garcı́a-Rey. (2003) A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation. Journal of Hepatology 38:6, pages 811-817.
Crossref
Crossref
M Angelis. (2003) Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transplantation 9:5, pages 451-462.
Crossref
Crossref
Chi-Jen Chu, Munira Hussain & Anna S. F. Lok. (2002) Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36:6, pages 1408-1415.
Crossref
Crossref
T Pruett. (2002) Indefinite passive immunization after liver transplantation for hepatitis B. Liver Transplantation 8:10, pages S88-S89.
Crossref
Crossref
S Muñoz. (2002) Use of hepatitis B core antibody–positive donors for liver transplantation. Liver Transplantation 8:10, pages S82-S87.
Crossref
Crossref
Chi-Jen Chu & Anna Suk-Fong Lok. (2002) Clinical utility in quantifying serum HBV DNA levels using PCR assays. Journal of Hepatology 36:4, pages 549-551.
Crossref
Crossref
Jonathan Hoare, Frank Henkler, Jason J. Dowling, William Errington, Robert D. Goldin, David Fish & Michael J. McGarvey. (2001) Subcellular localisation of the X protein in HBV infected hepatocytes. Journal of Medical Virology 64:4, pages 419-426.
Crossref
Crossref
Raymond T. Chung, Sandy Feng & Francis L. Delmonico. (2001) Approach to the Management of Allograft Recipients Following the Detection of Hepatitis B Virus in the Prospective Organ Donor. American Journal of Transplantation 1:2, pages 185-191.
Crossref
Crossref